an experimental experience

https://www.labiotech.eu/trends-news/shasqi-phase-2-solid-tumor-study/

9/12/22 at 10:39am

Organization

Author

Jim Cornall

Summarize

Cancer Health Shasqi SQ3370

Shasqi says it has opened the phase 2 part of its phase 1/2a clinical study to further assess SQ3370 in anthracycline-naïve patients.

Create an account or login to join the discussion